[HTML][HTML] Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
DL Baker, ML Schmidt, SL Cohn… - … England Journal of …, 2010 - Mass Medical Soc
Background The survival rate among patients with intermediate-risk neuroblastoma who
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
[PDF][PDF] Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris… - N Engl J …, 2010 - researchgate.net
BACKGROUND—The survival rate among patients with intermediate-risk neuroblastoma
who receive dose-intensive chemotherapy is excellent, but the survival rate among patients …
who receive dose-intensive chemotherapy is excellent, but the survival rate among patients …
[引用][C] Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris… - N. Engl. J …, 2010 - hsrc.himmelfarb.gwu.edu
"Outcome after reduced chemotherapy for intermediate-risk neuroblastoma" by DL Baker, ML
Schmidt et al. Home Search Browse Collections My Account About DC Network Digital …
Schmidt et al. Home Search Browse Collections My Account About DC Network Digital …
[引用][C] Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
DL BAKER, ML SCHMIDT… - The New England …, 2010 - pascal-francis.inist.fr
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
DL Baker, ML Schmidt, SL Cohn… - The New England …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The survival rate among patients with intermediate-risk neuroblastoma who
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
[HTML][HTML] Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris… - The New England …, 2010 - ncbi.nlm.nih.gov
BACKGROUND The survival rate among patients with intermediate-risk neuroblastoma who
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
[PDF][PDF] Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris… - N Engl J Med, 2010 - academia.edu
BACKGROUND—The survival rate among patients with intermediate-risk neuroblastoma
who receive dose-intensive chemotherapy is excellent, but the survival rate among patients …
who receive dose-intensive chemotherapy is excellent, but the survival rate among patients …
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris, WB London… - 2010 - indigo.uic.edu
Background The survival rate among patients with intermediate-risk neuroblastoma who
receivedose-intensive chemotherapy is excellent, but the survival rate among patients …
receivedose-intensive chemotherapy is excellent, but the survival rate among patients …
[引用][C] Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
DL Baker, ML Schmidt, SL Cohn, JM Maris… - New England Journal …, 2010 - cir.nii.ac.jp
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
DL Baker, ML Schmidt, SL Cohn, JM Maris… - The New England …, 2010 - europepmc.org
Background The survival rate among patients with intermediate-risk neuroblastoma who
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …
receive dose-intensive chemotherapy is excellent, but the survival rate among patients who …